US2021330989A1PendingUtilityA1

Systems and methods for laser-assisted topical treatment of nail fungal infections

Assignee: MASSACHUSETTS GEN HOSPITALPriority: Mar 15, 2019Filed: Jul 7, 2021Published: Oct 28, 2021
Est. expiryMar 15, 2039(~12.6 yrs left)· nominal 20-yr term from priority
A61B 18/203A61B 2018/20353A61B 2018/00732A61B 2017/00765A61B 2018/0016A61M 37/00A61B 2018/00184A61B 2018/20355A61N 5/062A61N 2005/0662A61B 2018/00761A61B 2018/00577A61B 2018/00702A61B 2018/00315A61M 35/00A61B 2018/00708A61N 5/0624A61N 2005/0661A61N 2005/0659A61N 5/067A61N 2005/0643A61N 5/01A61N 2005/067
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods for a laser-assisted topical treatment of nail fungal infections are provided. The laser-assisted topical treatment includes a laser that is configured to output a beam that penetrates the infected nail and creates a channel therethrough. The laser-assisted topical treatment further includes a treatment agent comprising a vehicle and a drug. The treatment agent is applied to an exterior surface of the infected nail so that the treatment agent may flow into the channel.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A laser-assisted topical treatment system for treating an infected nail, the treatment system comprising:
 a laser; and   a treatment agent comprising a vehicle and a drug;   wherein the laser is configured to output a beam that penetrates the infected nail and creates a plurality of channels therethrough; and   wherein the treatment agent is applied to a surface of the infected nail and flows into the plurality of channels.   
     
     
         2 . The treatment system of  claim 1 , further comprising an actuator, wherein the actuator is configured to move the laser along a path. 
     
     
         3 . The treatment system of  claim 1 , wherein the plurality of channels define widths of 250 micrometers or less. 
     
     
         4 . The treatment system of  claim 1 , wherein the plurality of channels are spaced less than 1 millimeter apart. 
     
     
         5 . The treatment system of  claim 4 , wherein the plurality of channels are spaced 50 to 200 micrometers apart. 
     
     
         6 . The treatment system of  claim 1 , wherein the plurality of channels are arranged in a distal portion of the infected nail. 
     
     
         7 . The treatment system of  claim 1 , wherein the plurality of channels are arranged in a proximal portion of the infected nail. 
     
     
         8 . The treatment system of  claim 1 , wherein the vehicle comprises at least one of epoxy resins, acrylates, silicone, rubber, fiberglass, keratin, collagen, or casein. 
     
     
         9 . The treatment system of  claim 1 , wherein the treatment agent defines a refractive index between 1.45 and 1.55. 
     
     
         10 . The treatment system of  claim 1 , further comprises a plurality of lasers. 
     
     
         11 . The treatment system of  claim 10 , wherein the plurality of lasers are configured to move along parallel paths. 
     
     
         12 . The treatment system of  claim 1 , wherein the laser is a near-infrared laser or ultraviolet laser. 
     
     
         13 . The treatment system of  claim 1 , wherein the laser is configured to output the beam with a wavelength of 400 nanometers or less. 
     
     
         14 . The treatment system of  claim 1 , wherein the laser is configured to move along a path. 
     
     
         15 . The treatment system of  claim 14 , wherein the path the laser moves along is linear. 
     
     
         16 . The treatment system of  claim 14 , wherein the path the laser moves along is curved. 
     
     
         17 . The treatment system of  claim 1 , further comprising an enclosure arranged to enclose the infected nail. 
     
     
         18 . The treatment system of  claim 17 , wherein the enclosure is connected to a pressure source that is configured to provide alternating positive and negative pressure to the infected nail to promote distribution of the treatment agent in the plurality of channels.

Join the waitlist — get patent alerts

Track US2021330989A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.